Category Archives: Generic drug

Pacific Rim Treaty threatens public health: patent law and medical procedures

Source: Elgar online Alexandra Phelan and Matthew Rimmer Doctors, surgeons, and physicians around the Pacific Rim should be concerned by the proposals revealed by WikiLeaks in the Trans-Pacific Partnership (TPP). One of the most controversial features of the TPP is the proposal … Continue reading

Posted in access to medicines, Compulsory Licensing, Drug Pricing, Generic drug, IP Rights, IPR Enforcement, patent, Right to Health, TPPA, Trans-Pacific Partnership Agreement, TRIPS, USTR 301 report, WHO, WTO | Tagged , , , , | Leave a comment

TPP draft reveals surgical strike on public health

Source: East Asia Forum On 13 November, WikiLeaks released a secret draft text of the Intellectual Property Chapter of the Trans-Pacific Partnership (TPP). The text reveals substantive proposals for expanded protection in respect of copyright, patent, trade mark andtrade secrets law, and intellectual property enforcement. Across this, there … Continue reading

Posted in access to medicines, Compulsory Licensing, Doha Declaration, Generic drug, IP Rights, patent, Right to Health, TPPA, Trans-Pacific Partnership Agreement, TRIPS, TRIPS plus, USTR 301 report, WHO, WTO | Leave a comment

Is the Global Fund Heading Backwards on Access to Medicines?

Source: PLOS Suerie Moon from the Harvard School of Public Health warns against falling back on stale solutions for ensuring access to essential medicines.  For nearly a decade, a bright spot on World AIDS Day has been steady growth in the number … Continue reading

Posted in access to medicines, Drug Pricing, Generic drug, HIV/Aids, IP Rights, IPR Enforcement, patent, Right to Health, TB, Tuberculosis and Malaria, WHO | Tagged , , , , | Leave a comment

Outrageous US bullying on intellectual property and health in TPPA talks in Salt Lake City

Source: Scoop ‘The US has adopted a strategy of exhaustion in its bullying of negotiators on the crucial intellectual property chapter to force countries to trade away health in the Trans-Pacific Partnership Agreement negotiations in Salt Lake City’, according to … Continue reading

Posted in access to medicines, Generic drug, IP Rights, patent, Patent examination system, Right to Health, TPPA, Trans-Pacific Partnership Agreement, USTR 301 report | Leave a comment

Secretive trade pact called ‘most harmful ever’ for affordable medicine

Source: Global Post Global health advocates say the Trans-Pacific Partnership, a proposed trade agreement between the US and 11 other countries, is an attack on public health. Part of the proposal was published by WikiLeaks last week. SALT LAKE CITY — “Humans before profit!” … Continue reading

Posted in access to medicines, Biologics, Drug Pricing, Generic drug, IP Rights, IPR Enforcement, patent evergreening, Right to Health, TPPA, Trans-Pacific Partnership Agreement | Leave a comment

How Much? A Battle Over The Cost Of The New Hepatitis C Drugs

Source: Pharmalive As excitement mounts among physicians and investors over a new crop of drugs for treating hepatitis C, there is also concern that patients in developing countries may not have sufficient access due to high prices. But a recent … Continue reading

Posted in access to medicines, Drug Pricing, Generic drug, Hepatitis - C, HIV/Aids, IP Rights, patent | Tagged , | 1 Comment

South Africa Embraces Compulsory Licensing Over AIDS Crisis

Source: Pharmalive Two months after releasing a draft policy for governing intellectual property, South Africa has decided to amend its patent legislation so the government can use parallel importing and compulsory licensing that is allowed under international agreements, according to … Continue reading

Posted in access to medicines, Compulsory Licensing, Generic drug, HIV/Aids, IP Rights, patent, Right to Health, South Africa's Patent Act, TRIPS, TRIPS flexibilities, WTO | Tagged | Leave a comment

MSFquote–Documents disclosed by WikiLeaks add to doubts over U.S.-led Pacific Rim trade deal in 2013

Source: Edmonton Journal The aid group Doctors Without Borders objected to stringent protections for patents on pharmaceuticals that would benefit drug companies, one of the chief objectives of the trade talks. The document “confirms that the U.S. government continues to … Continue reading

Posted in access to medicines, Generic drug, HIV/Aids, IP Rights, IPR Enforcement, patent, TB, TPPA, Trans-Pacific Partnership Agreement | Leave a comment

WikiLeaks shines rare light onto US trade negotiations

Source: Aljazeera America Leak details intellectual property rights deal in Trans-Pacific Partnership under negotiation between US and 10 nations US President Barack Obama poses for a photograph with Trans-Pacific Partnership leaders. In its latest document dump, WikiLeaks unearthed what it … Continue reading

Posted in access to medicines, Drug Pricing, Generic drug, IP Rights, IPR Enforcement, Medicine Patent Pool, Right to Health, Trans-Pacific Partnership Agreement, transparency | Tagged , , | Leave a comment

Will The New Hepatitis C Drugs Trigger A Battle Over Cost?

Source: Forbes As excitement mounts among physicians and investors over a new batch of drugs for treating hepatitis C, there is also concern that patients in developing countries may not have sufficient access due to high prices. But a recent … Continue reading

Posted in access to medicines, Compulsory Licensing, Drug Pricing, Generic drug, Hepatitis - C, HIV/Aids | Tagged , , , , | Leave a comment